Loblaw Companies (TSE:L – Get Free Report) was upgraded by equities research analysts at Scotiabank to a “strong-buy” rating in a research note issued on Friday,Zacks.com reports.
A number of other brokerages also recently issued reports on L. Royal Bank of Canada raised their price target on shares of Loblaw Companies from C$205.00 to C$217.00 and gave the stock an “outperform” rating in a report on Monday, December 9th. Desjardins lifted their target price on Loblaw Companies from C$172.00 to C$190.00 in a research report on Thursday, November 14th. National Bankshares upped their target price on shares of Loblaw Companies from C$188.00 to C$195.00 in a research report on Thursday, November 14th. UBS Group set a C$225.00 price objective on shares of Loblaw Companies and gave the stock a “buy” rating in a research report on Friday, December 13th. Finally, CIBC upped their price target on Loblaw Companies from C$189.00 to C$206.00 in a research note on Thursday, November 14th. One investment analyst has rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Loblaw Companies has a consensus rating of “Buy” and an average price target of C$197.00.
View Our Latest Stock Analysis on Loblaw Companies
Loblaw Companies Stock Up 0.0 %
Insider Transactions at Loblaw Companies
In related news, Director Christie James Beckett Clark sold 2,105 shares of the company’s stock in a transaction that occurred on Wednesday, December 18th. The stock was sold at an average price of C$189.69, for a total value of C$399,297.45. Corporate insiders own 53.77% of the company’s stock.
Loblaw Companies Company Profile
Loblaw is one of Canada’s largest grocery, pharmacy, and general merchandise retailers, operating the most expansive store footprint in Ontario and maintaining sizable presences in provinces like Quebec and British Columbia. Key grocery banners include Loblaw, No Frills, and Maxi, while its pharmaceutical operations are the product of its 2014 acquisition of Shoppers Drug Mart.
See Also
- Five stocks we like better than Loblaw Companies
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Top 3 ETFs to Hedge Against Inflation in 2025
- What is a buyback in stocks? A comprehensive guide for investors
- These 3 Chip Stock Kings Are Still Buys for 2025
- Consumer Staples Stocks, Explained
- MarketBeat Week in Review – 12/23 – 12/27
Receive News & Ratings for Loblaw Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loblaw Companies and related companies with MarketBeat.com's FREE daily email newsletter.